THE EFFECT OF LISINOPRIL ON BLOOD GLUCOSE LEVEL
AbstractKhalid Mahmood Qureshi, Raja Zafar Ahmed, Misbahul Islam Khan, Nusrat PashaThe aim of this study was to evaluate the effect of lisinopril on glucose metabolism in mild to moderate hypertensivenon-insulin dependent diabetic patients. One hundred and twenty patients were divided into two groups. Group-A wasgiven placebo of lisinopril for two weeks. Group-B was given lisinopril in a fixed dose of 10 mg once daily for twoweeks. Comparison of fasting blood glucose levels before and after the treatment showed that the blood glucose levelwas almost unchanged.
Carlos A, FachecO, Levis C et at. Hypoglycemic
induced by angiotensin converting enzyme inhibition in
patients with non-insulin dependent diabetes mellitus
receiving sulfonylurea therapy. Am J Med 1990;
Gordon II. William S. Harrison’s principles of internal
medicine. Wilson, Braunwald. Issel Bacher, Petersdrof,
Martin, Fanci and Root 1991;12:1001-14.
Melvin J. Prince, Charles A et al: Metabolic effects of
hydrochlorothiazide and enalapril during treatment of
the hypertensive diabetic patients. Arch intern Med
Shinoiri H. Veda S, Gotohe et al: Glucose and lipid
metabolism during long term linsinopril therapy in
hypertensive patients. J Cardiovac Pharmacol 1990;
Thomas P, Hans L, Christen B: A comparison of the
effects of hydrochlorothiazide and captopril on glucose
and lipid metabolism in patients with hypertensive. N
Eng J Med 1989; 321: 868-73.
Thurig C, Bohlen L, Dshneider M et al: Insulin is
neutral to insulin sensitivity and serum lipoproteins in
essential hypertensive patients. Eur J Clin Pharmacol
; 49(1-2): 21-26.
Reaven GM, Clinking beard C, Jeppesen J et al:
Comparison of the hemodynamic and metabolic effects
of low dose hydrochlorothiazide and lisinopril
treatment in obese patients with high blood pressure.
Am J Hypertens 1995; 8:461-66.
Crepaldi G, Garraro A. Brocco E Et al. Hypertension
and non-insulin dependent diabetes. A comparison
between an angiotensin converting enzyme inhibitors
and-a calcium antagonist. Acta Diabetol 1995; 32(3):
Fogaria R. Zoppi A, Malamani GD et al. Effects of
different antihypertensive drugs on plasma fibronogen
in hypertension patients. Br J Clin Pharmacol 1995;